Blood Test

In this Healio video exclusive, Charles J. Meakin, MD, MHA, chief medical officer of Care Oncology, discusses risk factors for colorectal cancer, the importance of early detection and the use of liquid biopsies as screening tools.

A lipid profiling blood test may predict the risk for type 2 diabetes and CVD years in advance, according to findings published in PLOS Biology.

A blood test at the time of diagnosis can predict the severity of COVID-19-related illness and a patient’s risk for death, according to a small study published in PLoS One.

Healio Psychiatry’s five most-viewed stories in November highlight the link between alopecia areata and dementia risk, a blood test that may identify Alzheimer’s disease symptoms, and regulatory developments.

A blood test may be able to identify individuals at increased risk for developing Alzheimer’s disease symptoms, according to research presented at the Clinical Trials on Alzheimer’s Disease conference.

A new blood test could rapidly identify placenta accreta spectrum disorder, according to researchers.

A blood-based test demonstrated efficacy and high specificity in detecting multiple cancer types with diverse biological features, paving the way for a new screening option, according to research published in Annals of Oncology.

When given a choice, participants preferred fecal immunochemical test-based screening for colorectal cancer compared with a blood test, according to research presented at Digestive Disease Week.

A noninvasive multimodal blood test demonstrated high sensitivity and specificity for the detection of colorectal advanced neoplasia, according to prospective study results presented at Gastrointestinal Cancers Symposium.

Pancreatic ductal adenocarcinoma historically has been a challenging cancer to treat, and often is not detected until it has progressed and metastasized. Some subtypes respond well to chemotherapy, whereas others are resistant.